Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Seroquel XR and risperidone on depressive symptoms in schizophrenia and schizoaffective disorder
2007-004246-32Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of quetiapine in schizophrenia and schizoaffective disorder (2 arms), sponsored by AstraZeneca. Primary endpoint: Depressive symptoms (CDSS). Started Dec 2007; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on 2007-004246-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004246-32.